We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
(+19%)
Cap. Flow
+$792M
Cap. Flow
% of AUM
14.77%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$82.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$78.3M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$57.7M |
| 4 |
Teradyne
TER
|
+$56.1M |
| 5 |
AbbVie
ABBV
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$66.1M |
| 2 |
Zimmer Biomet
ZBH
|
+$56.1M |
| 3 |
NVIDIA
NVDA
|
+$55.8M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$54.7M |
| 5 |
eBay
EBAY
|
+$40.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.89% |
| 2 | Technology | 25.02% |
| 3 | Communication Services | 8.75% |
| 4 | Financials | 5.58% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAPA
101
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $14.3M | 0.27% |
646,846
-889
| -0.1% | -$17.3K |
|
102
AnaptysBio
ANAB
$1.58B
| $14M | 0.26% |
540,052
+111,205
| +26% | +$2.67M |
|
103
Petco
WOOF
$797M
| $13.9M | 0.26% |
621,685
+216,532
| +53% | +$5.06M |
|
104
Colgate-Palmolive
CL
$73.1B
| $13.9M | 0.26% |
+171,155
| New | +$14M |
|
105
Monolithic Power Systems
MPWR
$70.1B
| $13.8M | 0.26% |
+36,855
| New | +$13M |
|
|
CMLTU
106
DELISTED
CM Life Sciences III Inc. Unit
CMLTU
| $13.7M | 0.26% |
+1,250,000
| New | +$13.5M |
|
107
argenx
ARGX
$53.4B
| $13.5M | 0.25% |
44,769
+38,229
| +585% | +$10.9M |
|
108
Charles River Laboratories
CRL
$11.2B
| $13.3M | 0.25% |
35,876
+4,140
| +13% | +$1.38M |
|
109
Knowles
KN
$3.13B
| $13.2M | 0.25% |
667,488
+145,323
| +28% | +$2.96M |
|
110
McKesson
MCK
$100B
| $13.1M | 0.25% |
68,701
+17,993
| +35% | +$3.48M |
|
111
Ambarella
AMBA
$3.77B
| $13M | 0.24% |
+121,904
| New | +$12.1M |
|
|
ZGNX
112
DELISTED
Zogenix, Inc.
ZGNX
| $12.8M | 0.24% |
741,559
-306,057
| -29% | -$5.63M |
|
|
VERV
113
DELISTED
Verve Therapeutics
VERV
| $12.5M | 0.23% |
+206,921
| New | +$8.59M |
|
114
Constellation Brands
STZ
$22.2B
| $12.2M | 0.23% |
+51,951
| New | +$12.2M |
|
|
KRON
115
DELISTED
Kronos Bio
KRON
| $12M | 0.22% |
500,628
+312,543
| +166% | +$7.91M |
|
116
Flex
FLEX
$41.7B
| $12M | 0.22% |
890,250
+453,489
| +104% | +$6.16M |
|
|
BHVN
117
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $11.9M | 0.22% |
122,408
-65,848
| -35% | -$5.34M |
|
118
Spotify
SPOT
$103B
| $11.9M | 0.22% |
43,082
+13,217
| +44% | +$3.35M |
|
119
ARS Pharmaceuticals
SPRY
$509M
| $11.7M | 0.22% |
377,631
+170,948
| +83% | +$5.48M |
|
120
Fate Therapeutics
FATE
$286M
| $11.4M | 0.21% |
131,106
+4,746
| +4% | +$382K |
|
121
Centene
CNC
$30.7B
| $11.3M | 0.21% |
155,017
-320,048
| -67% | -$21.9M |
|
122
Insmed
INSM
$21.4B
| $11.3M | 0.21% |
+396,551
| New | +$11.8M |
|
123
Hewlett Packard
HPE
$63.4B
| $11.2M | 0.21% |
+769,160
| New | +$12.1M |
|
124
Legend Biotech
LEGN
$3.59B
| $11.2M | 0.21% |
+273,043
| New | +$9.28M |
|
|
FYBR
125
DELISTED
Frontier Communications
FYBR
| $11.2M | 0.21% |
+422,713
| New | +$10.6M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.
- Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
- Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
- Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
- Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
- Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
- Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
- Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.
Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.